Terms: = Head and neck cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Prognosis
20 results:
1. Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review.
Domański P; Piętak M; Staneta S; Fortuniak W; Kruczyk B; Kobiernik A; Bakuła P; Mydlak A; Demkow T; Sikora-Kupis B; Dumnicka P; Kucharz J
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541124
[No Abstract] [Full Text] [Related]
2. Tumor hypoxia and role of hypoxia-inducible factor in oral cancer.
Singh P; Rajput M; Pandey M
World J Surg Oncol; 2024 Jan; 22(1):18. PubMed ID: 38200568
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing vhl through a non-canonical function of EZH2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
4. A Positive Feedback Loop between Inactive vhl-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression.
Yang J; Luo L; Zhao C; Li X; Wang Z; Zeng Z; Yang X; Zheng X; Jie H; Kang L; Li S; Liu S; Zhou C; Liu H
Int J Biol Sci; 2022; 18(8):3470-3483. PubMed ID: 35637958
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological and Molecular Features of Secondary cancer (Metastasis) to the Thyroid and Advances in Management.
Nguyen M; He G; Lam AK
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328664
[TBL] [Abstract] [Full Text] [Related]
6. [Endocrine and neuroendocrine tumors].
Riss P; Scheuba K; Strobel O
Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
[TBL] [Abstract] [Full Text] [Related]
7. miRNA-21 promotes cell proliferation and invasion via vhl/PI3K/AKT in papillary thyroid carcinoma.
Zang C; Sun J; Liu W; Chu C; Jiang L; Ge R
Hum Cell; 2019 Oct; 32(4):428-436. PubMed ID: 31161410
[TBL] [Abstract] [Full Text] [Related]
8. The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer.
Jin A; Xu J; Wang Y
Medicine (Baltimore); 2018 Jul; 97(29):e11548. PubMed ID: 30024548
[TBL] [Abstract] [Full Text] [Related]
9. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.
Andrade MO; Cunha VSD; Oliveira DC; Moraes OL; Lofrano-Porto A
Arch Endocrinol Metab; 2018; 62(2):264-269. PubMed ID: 29768630
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological features of low-grade malignant endolymphatic sac tumors.
Wang HQ; Jie L; Shi HY
Pathol Res Pract; 2018 Mar; 214(3):431-435. PubMed ID: 29482989
[TBL] [Abstract] [Full Text] [Related]
11. Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies.
Zanoletti E; Girasoli L; Borsetto D; Opocher G; Mazzoni A; Martini A
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):423-429. PubMed ID: 29165437
[TBL] [Abstract] [Full Text] [Related]
12. Deregulated expression of vhl mRNA variants in papillary thyroid cancer.
Baldini E; Tuccilli C; Arlot-Bonnemains Y; Chesnel F; Sorrenti S; De Vito C; Catania A; D'Armiento E; Antonelli A; Fallahi P; Watutantrige-Fernando S; Tartaglia F; Barollo S; Mian C; Bononi M; Arceri S; Mascagni D; Vergine M; Pironi D; Monti M; Filippini A; Ulisse S
Mol Cell Endocrinol; 2017 Mar; 443():121-127. PubMed ID: 28089820
[TBL] [Abstract] [Full Text] [Related]
13. Loss of vhl expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
[TBL] [Abstract] [Full Text] [Related]
14. The genetics of paragangliomas.
Burnichon N; Abermil N; Buffet A; Favier J; Gimenez-Roqueplo AP
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Dec; 129(6):315-8. PubMed ID: 23078982
[TBL] [Abstract] [Full Text] [Related]
15. HDAC2 promotes cell migration/invasion abilities through HIF-1α stabilization in human oral squamous cell carcinoma.
Chang CC; Lin BR; Chen ST; Hsieh TH; Li YJ; Kuo MY
J Oral Pathol Med; 2011 Aug; 40(7):567-75. PubMed ID: 21332579
[TBL] [Abstract] [Full Text] [Related]
16. The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.
Chen MF; Lee KD; Lu MS; Chen CC; Hsieh MJ; Liu YH; Lin PY; Chen WC
J Mol Med (Berl); 2009 Mar; 87(3):307-20. PubMed ID: 19083192
[TBL] [Abstract] [Full Text] [Related]
17. Loss of heterozygosity of the vhl gene identifies malignancy and predicts death in follicular thyroid tumors.
Hunt JL; Yim JH; Tometsko M; Finkelstein SD; Swalsky P; Carty SE
Surgery; 2003 Dec; 134(6):1043-7; discussion 1047-8. PubMed ID: 14668739
[TBL] [Abstract] [Full Text] [Related]
18. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
Le QT; Sutphin PD; Raychaudhuri S; Yu SC; Terris DJ; Lin HS; Lum B; Pinto HA; Koong AC; Giaccia AJ
Clin Cancer Res; 2003 Jan; 9(1):59-67. PubMed ID: 12538452
[TBL] [Abstract] [Full Text] [Related]
19. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract] [Full Text] [Related]
20. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
[TBL] [Abstract] [Full Text] [Related]
